Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhaled nitric oxide.

J D Roberts1, W M Zapol

  • 1Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston 02129, USA.

Seminars in Perinatology
|March 10, 2000
PubMed
Summary
This summary is machine-generated.

Inhaled nitric oxide (NO) safely reduces pulmonary artery hypertension and improves oxygen levels in newborns. It may also prevent lung injury-related pulmonary artery disease by modulating cell proliferation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling underwater noise propagation from marine hydrokinetic power devices through a time-domain, velocity-pressure solution.

The Journal of the Acoustical Society of America·2018
Same author

TERTIARY SPECIATION MODELS IN AUSTRALIAN ANURANS: MOLECULAR DATA CHALLENGE PLEISTOCENE SCENARIO.

Evolution; international journal of organic evolution·2017
Same author

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study.

The pharmacogenomics journal·2015
Same author

Our paper 20 years later: Inhaled nitric oxide for the acute respiratory distress syndrome--discovery, current understanding, and focussed targets of future applications.

Intensive care medicine·2014
Same author

The role of phylogeny and ecology in shaping morphology in 21 genera and 127 species of Australo-Papuan myobatrachid frogs.

Journal of evolutionary biology·2013
Same journal

Congenital cytomegalovirus: Screening strategies and diagnostic challenges.

Seminars in perinatology·2026
Same journal

The society for neonatal nutrition and lifelong health: Building science and translating research to inform neonatal nutritional care.

Seminars in perinatology·2026
Same journal

Enteral nutrition to optimize health and neurodevelopmental outcomes in very preterm infants.

Seminars in perinatology·2026
Same journal

Standardizing outcome measures in preterm infant nutrition research: Use of anthropometry and body composition in the neonatal intensive care unit.

Seminars in perinatology·2026
Same journal

A dilemma of parental inclusion? Parent perspectives of NICU feeding practices and neonatal nutritional research.

Seminars in perinatology·2026
Same journal

Maternal diet and nutritional status during pregnancy and lactation: a review of implications on milk composition and lactation outcomes.

Seminars in perinatology·2026
See all related articles

Area of Science:

  • Pulmonary Medicine
  • Vascular Biology
  • Neonatology

Background:

  • Nitric oxide (NO) is a key signaling molecule in pulmonary vasculature, mediating vasodilation.
  • Endogenous NO, produced from L-arginine, acts locally in vascular smooth muscle, with minimal systemic effects.
  • NO plays a role in regulating cell proliferation and vascular remodeling.

Purpose of the Study:

  • To review the therapeutic potential of inhaled nitric oxide (NO) in managing pulmonary hypertension.
  • To explore NO's effects on systemic oxygenation and the need for mechanical support in neonates.
  • To examine NO's role in modulating pulmonary vascular proliferation and preventing lung injury-related disease.

Main Methods:

  • Review of clinical studies and recent research on inhaled nitric oxide therapy.

Related Experiment Videos

  • Analysis of NO's physiological effects on pulmonary and systemic circulation.
  • Investigation of NO's impact on cellular proliferation in the pulmonary artery.

    • Main Results:

    • Inhaled NO effectively decreases pulmonary artery hypertension without causing systemic hypotension.
    • Clinical studies show inhaled NO improves systemic oxygen levels in hypoxemic newborns, reducing extracorporeal membrane oxygenation needs.
    • Emerging evidence suggests inhaled NO selectively modulates pulmonary artery proliferation associated with lung injury.

    Conclusions:

    • Inhaled nitric oxide is a safe and effective treatment for pulmonary hypertension in various patient groups.
    • NO therapy offers significant benefits in neonatal respiratory distress and pulmonary hypertension.
    • Inhaled NO holds promise for attenuating or preventing pulmonary artery disease in patients with lung injury.